Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Sanofi uploaded the video recording of its Investor/Analysts Call, held on August 5, 2026. The call provided updates on the unaudited financial results for the quarter and half-year ended June 30, 2026.
Aug 06 2026 11:20:07
Sanofi India Ltd - 500674 - Intimation Under Regulation 30(5) Of The Listing Regulations
Sanofi India Ltd announced that Mr. Rachid Ayari will step down from his roles as Whole Time Director and Chief Financial Officer, effective September 30, 2026. This change will remove his name from the list of Key Managerial Personnel authorized for materiality determination.
Aug 04 2026 20:24:17
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Resignation of Director
Sanofi India's Whole Time Director, CFO, and KMP, Mr. Rachid Ayari, is resigning effective September 30, 2026. This transition is for another role within the broader Sanofi group. The company is seeking a suitable replacement.
Jul 23 2026 10:45:58
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Management
Sanofi announced the resignation of Mr. Rachid Ayari from his roles as Whole Time Director, Chief Financial Officer, and Key Managerial Personnel, effective September 30, 2026. He will be transitioning to another role within the Sanofi group, with the company initiating a search for his replacement.
Jul 23 2026 10:22:39
Sanofi India Ltd - 500674 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026.
Sanofi India's Board of Directors is scheduled to meet on August 4, 2026. The agenda includes considering and approving the unaudited financial results for the quarter and half year ended June 30, 2026 (Q1 & H1 FY27).
Jul 20 2026 12:18:18
Read More